Accuracy and efficacy of pre-dengue vaccination screening for previous dengue infection with five commercially available immunoassays: a retrospective analysis of phase 3 efficacy trials

BACKGROUND: The tetravalent dengue vaccine (CYD-TDV) has been shown to provide protection against dengue disease over 5-year follow-up in participants with previous dengue infection, but increased the risk of dengue hospitalisation and severe dengue during long-term follow-up in those without previo...

Descripción completa

Detalles Bibliográficos
Autores principales: DiazGranados, Carlos A, Bonaparte, Matthew, Wang, Hao, Zhu, Ming, Lustig, Yaniv, Schwartz, Eli, Forrat, Remi, Dayan, Gustavo H, Hodge, Shekema, Ataman-Önal, Yasemin, Savarino, Stephen J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759790/
https://www.ncbi.nlm.nih.gov/pubmed/33212068
http://dx.doi.org/10.1016/S1473-3099(20)30695-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759790/
https://www.ncbi.nlm.nih.gov/pubmed/33212068
http://dx.doi.org/10.1016/S1473-3099(20)30695-2

Ejemplares similares